Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.077 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |